L & S Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by L & S Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by L & S Advisors from 13F filings

Historical chart of L & S Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by L & S Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by L & S Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $268k 3.0k 90.70

More positions owned by L & S Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Facebook Inc cl a (META)
Spdr S&p 500 Etf (SPY)
Eli Lilly & Co. (LLY)
SPDR Dow Jones Industrial Average ETF (DIA)
Crowdstrike Hldgs Inc cl a (CRWD)
Diamondback Energy (FANG)
Citigroup (C)
Goldman Sachs (GS)
Us Treasury Fixed (Principal)
Exxon Mobil Corporation (XOM)
Walt Disney Company (DIS)

View all positions for L & S Advisors

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Northwestern Mutual Wealth Management Company
Miller Investment Management
Prime Capital Investment Advisors
Jpmorgan Chase & Co
Morgan Stanley
LPL Financial
Phoenix Holdings
Avestar Capital
J.Safra Asset Management
Susquehanna International
Citadel Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf